Let’s not gaslight the public shall we I know a few ‘diagnostic’...

First 89 Last

Share
Profile

Follow
Bullrush007

5,261 Posts.

633

23/02/24

12:57

Post #: 72559361
Share

Originally posted by jackherb: ↑

I don't need to be, just to read the presented results.

Imaging science research training goes a long way though to decipher what a crapy trial design and useless presented results these are.
You are clearly not an imaging biotech science based person.

I am not prepared to bring you up to speed to understand why this presented result release is at junior high school standard at best. That would take a very long time but I encourage you to print out this release and show/email whatever way you like to a radiologist for their opinion to ease your mind.

I fully understand that the majority of public investors wouldn't understand the importance of a meaningful trial design and what the results really mean but there is one line in the first paragraph that any layperson should shake their head about. See below.

"The trial ......showed that blinded radiologists MAY be able to distnguish suspicious lymph nodes..."

Let me tell you that you will never see a tech company become a FIC or BIC company in their field with the descriptive word 'MAY' used to describe results. Surely any Tom, Dick and Harriet can understand that. This really says a lot about the standard and quality about the IBX board.
Good luck.

Expand

Let’s not gaslight the public shall we

I know a few ‘diagnostic’ radiologists and they say this could definitely become a game changer

though I keep holding, this might not so be so much of a money maker

but for a potential mainstream early cancer detection tech and imagining technique - it’s a game changer - for that I follow with absolute interest and optimism

besides, they are already making over a mill in revenue from selling these nanoparticles. Not bad for a ‘Phase 1’ company

what’s not to like besides a lack of appropriate communication from the company

IBX Price at posting: 8.6¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply